Evidence map›Paper›PMID 31088588›Full record

ArticleEpidemiology and psychiatric sciences2019

A risk calculator to predict adult attention-deficit/hyperactivity disorder: generation and external validation in three birth cohorts and one clinical sample.

A Caye, J Agnew-Blais, L Arseneault, H Gonçalves, C Kieling, K Langley, A M B Menezes, T E Moffitt, I C Passos, T B Rocha and 5 more

Erratum issuedOpen access · hybridAbstract readValidation Study
In one paragraph

Article in Epidemiology and psychiatric sciences, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Heliyon · 2023
    Article
  10. Annual Research Review: Perspectives on progress in ADHD science - from characterization to cause.Journal of child psychology and psychiatry, and allied disciplines · 2023
    Review
  11. Review
  12. Article
  13. Frontiers in psychiatry · 2023
    Article
  14. Precision Psychiatry: The Future Is Now.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2022
    Article
  15. ADHD in Children and Adults: Diagnosis and Prognosis.Current topics in behavioral neurosciences · 2022
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Attention-deficit hyperactivity disorder.Lancet (London, England) · 2020
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 3 countries.

A CayeDepartment of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.
J Agnew-BlaisMRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
L ArseneaultMRC Social, Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, UK.
H GonçalvesPost-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.
C KielingDepartment of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.
K LangleyDivision of Psychological Medicine and Clinical Neurosciences; MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK.
A M B MenezesPost-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.
T E MoffittDepartment of Psychology and Neuroscience, Duke University, Durham, North Carolina, USA.
I C PassosGraduation Program in Psychiatry and Laboratory of Molecular Psychiatry, Federal University of Rio Grande do Sul, Porto Alegre, Brazil.
T B RochaDepartment of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.
M H SibleyDepartment of Psychiatry and Behavioral Health at the Florida International University, Herbert Wertheim College of Medicine, US.
J M SwansonDepartment of Pediatrics, University of California, Irvine, USA.
A ThaparSchool of Psychology, Cardiff University, Cardiff, UK.
F WehrmeisterPost-Graduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil.
L A RohdeDepartment of Psychiatry, Hospital de Clínicas de Porto Alegre, Federal University of Rio Grande do Sul, Brazil.
Universidade Federal de Pelotas · BRCardiff University · GBHospital de Clínicas de Porto Alegre · BRKing's College London · GBUniversidade Federal do Rio Grande do Sul · BRDuke University · USFlorida International University · USSupport group for adolescents and children with cancer · BRUniversity of California, Irvine · US

Funding

Medical Research Council G1002190Medical Research Council G9815508Medical Research Council MC_PC_19009Medical Research Council MR/L010305/1Medical Research Council MR/M012964/1Medical Research Council MR/P005918/1
6 · The paper itself

Abstract

aimFew personalised medicine investigations have been conducted for mental health. We aimed to generate and validate a risk tool that predicts adult attention-deficit/hyperactivity disorder (ADHD).

methodsUsing logistic regression models, we generated a risk tool in a representative population cohort (ALSPAC - UK, 5113 participants, followed from birth to age 17) using childhood clinical and sociodemographic data with internal validation. Predictors included sex, socioeconomic status, single-parent family, ADHD symptoms, comorbid disruptive disorders, childhood maltreatment, ADHD symptoms, depressive symptoms, mother's depression and intelligence quotient. The outcome was defined as a categorical diagnosis of ADHD in young adulthood without requiring age at onset criteria. We also tested Machine Learning approaches for developing the risk models: Random Forest, Stochastic Gradient Boosting and Artificial Neural Network. The risk tool was externally validated in the E-Risk cohort (UK, 2040 participants, birth to age 18), the 1993 Pelotas Birth Cohort (Brazil, 3911 participants, birth to age 18) and the MTA clinical sample (USA, 476 children with ADHD and 241 controls followed for 16 years from a minimum of 8 and a maximum of 26 years old).

resultsThe overall prevalence of adult ADHD ranged from 8.1 to 12% in the population-based samples, and was 28.6% in the clinical sample. The internal performance of the model in the generating sample was good, with an area under the curve (AUC) for predicting adult ADHD of 0.82 (95% confidence interval (CI) 0.79-0.83). Calibration plots showed good agreement between predicted and observed event frequencies from 0 to 60% probability. In the UK birth cohort test sample, the AUC was 0.75 (95% CI 0.71-0.78). In the Brazilian birth cohort test sample, the AUC was significantly lower -0.57 (95% CI 0.54-0.60). In the clinical trial test sample, the AUC was 0.76 (95% CI 0.73-0.80). The risk model did not predict adult anxiety or major depressive disorder. Machine Learning approaches did not outperform logistic regression models. An open-source and free risk calculator was generated for clinical use and is available online at https://ufrgs.br/prodah/adhd-calculator/.

conclusionsThe risk tool based on childhood characteristics specifically predicts adult ADHD in European and North-American population-based and clinical samples with comparable discrimination to commonly used clinical tools in internal medicine and higher than most previous attempts for mental and neurological disorders. However, its use in middle-income settings requires caution.

Indexed as

IntelligenceSocial ClassAdolescentArea Under CurveAttention Deficit and Disruptive Behavior DisordersAttention Deficit Disorder with HyperactivityChildChild AbuseCohort StudiesConduct DisorderDepressionDepressive DisorderFemaleHumansIntelligence TestsLogistic ModelsAttention-deficit hyperactivity disorderchild psychiatryepidemiologyrisk factorsstatistics

Identifiers

PMID31088588
PMCPMC8061253
OpenAlexW2942159151

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.